Simultaneous targeting of AMPK and mTOR is a novel therapeutic strategy against prostate cancer
G. Zhao, G. Forn-Cuni, M. Scheers…·E. B. Snaar
This study shows that targeting both AMPK and mTOR can inhibit prostate cancer metastasis by blocking the metabolic switch required for tumor growth in new environments.